Revisiting Antiarrhythmic Drug Therapy for Atrial Fibrillation: Reviewing Lessons Learned and Redefining Therapeutic Paradigms

Since the clinical use of digitalis as the first pharmacological therapy for atrial fibrillation (AF) 235 years ago in 1785, antiarrhythmic drug therapy has advanced considerably and become a cornerstone of AF clinical management. Yet, a preventive or curative panacea for sustained AF does not exist...

Descripción completa

Detalles Bibliográficos
Autores principales: Geng, Meng, Lin, Andrew, Nguyen, Thao P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7680856/
https://www.ncbi.nlm.nih.gov/pubmed/33240090
http://dx.doi.org/10.3389/fphar.2020.581837

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7680856/
https://www.ncbi.nlm.nih.gov/pubmed/33240090
http://dx.doi.org/10.3389/fphar.2020.581837

Ejemplares similares